Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease
-
Published:2019-10-29
Issue:1
Volume:3
Page:
-
ISSN:2509-8020
-
Container-title:Journal of Patient-Reported Outcomes
-
language:en
-
Short-container-title:J Patient Rep Outcomes
Author:
Yount Susan E.ORCID, Atwood Charles, Donohue James, Hays Ron D., Irwin Debra, Leidy Nancy Kline, Liu Honghu, Spritzer Karen L., DeWalt Darren A.
Abstract
Abstract
Background
Chronic obstructive pulmonary disease (COPD) is a progressive chronic disease characterized by airflow obstruction that leads to shortness of breath and substantial negative impacts on health-related quality of life (HRQL). The course of COPD includes periodic acute exacerbations that require changes in treatment and/or hospitalizations. This study was designed to examine the responsiveness of Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures to changes associated with COPD exacerbation recovery.
Methods
A longitudinal analysis using mixed-effects models was conducted of people who were enrolled while stable (n = 100) and those who experienced an acute exacerbation (n = 85). PROMIS (physical function, pain interference, pain behavior, fatigue, anxiety, depression, anger, social roles, discretionary social activities, Global Health, dyspnea severity and dyspnea functional limitations) and COPD-targeted HRQL measures were completed at baseline and at 12 weeks.
Results
We administered PROMIS measures using computer adaptive testing (CAT), followed by administration of any remaining short form (SF) items that had not yet been administered by CAT. Examination of the difference between group differences from baseline to 12 weeks in the stable and exacerbation groups revealed that the exacerbation group changed (improved) significantly more than the stable group in anxiety (p < .001 to p < .01; f2 effect size [ES] = 0.023/0.021), fatigue (p < .0001; ES = 0.036/0.047) and social roles (p < .001 to p < .05; ES = 0.035/0.024). All effect sizes were small in magnitude and smaller than hypothesized. Depression was also statistically significant (p < .05, SF only) but the ES was trivial. For all other PROMIS domains, the differences were not significant and ES were trivial.
Conclusions
This longitudinal study provides some support for the validity of the PROMIS fatigue, anxiety, and social roles domains in COPD, but further evaluation of responsiveness is warranted.
Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics
Reference93 articles.
1. Rennard, S. I. (1998). COPD: Overview of definitions, epidemiology, and factors influencing its development. Chest, 113(4 Suppl), 235S–241S. 2. Kochanek, K., Xu, J., Murphy, S., Miniño, A., & Kung, H. (2011). Deaths: Preliminary data for 2009. Hyattsville: National Center for Health Statistics. 3. National Institutes of Health National Heart Lung and Blood Institute. (2009). Morbidity & Mortality: Chart book on cardiovascular, lung, and blood diseases Retrieved January 2, 2011, from
http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf
. 4. Bausewein, C., Booth, S., Gysels, M., Kuhnbach, R., Haberland, B., & Higginson, I. J. (2010). Understanding breathlessness: Cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. Journal of Palliative Medicine, 13(9), 1109–1118. 5. Connors Jr., A. F., Dawson, N. V., Thomas, C., Harrell Jr., F. E., Desbiens, N., Fulkerson, W. J., Kussin, P., Bellamy, P., Goldman, L., & Knaus, W. A. (1996). Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). American Journal of Respiratory and Critical Care Medicine, 154(4 Pt 1), 959–967.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|